Referral for the group of younger patients is important because young age at diagnosis of breast cancer indicates a higher risk to carry a BRCA1 or BRCA2 pathogenic variant and is a clear indication for referral to breast cancer genetic testing [44]. Here, BRCA2 is linked to breast carcinoma.